Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  HYPERTENSION

• Publication date

  1988-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.HYP.11.4.376PMID 2895737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of nifedipine and hydralazine induced hypotension on sympathetic activity

  2004cited by this paper
• Time-course of changes in cardiac hypertrophy and pressor mechanisms in two-kidney, one clip hypertensive rats during treatment with minoxidil, enalapril or after uninephrectomy.

  1987influential reference
• Hemodynamic interaction of nonselective vs. beta‐1‐selective beta‐blockade with hydralazine in normal humans

  1987cited by this paper
• Cardiac dimensions in spontaneously hypertensive rats following different modes of blood pressure reduction by antihypertensive treatment.

  1986cited by this paper
• Effects of hydralazine on blood pressure, pressor mechanisms, and cardiac hypertrophy in two-kidney, one-clip hypertensive rats.

  1986cited by this paper
• Effects of hydralazine and sodium nitroprusside on plasma catecholamines and heart rate.

  1985cited by this paper
• Cardiac mass and peripheral vascular structure in hydralazine-treated spontaneously hypertensive rats.

  1985cited by this paper
• Effect of hydralazine on serial measurements of exchangeable sodium and blood pressure in spontaneously hypertensive rats.

  1985cited by this paper
• Effects of minoxidil on blood pressure and cardiac hypertrophy in two-kidney, one-clip hypertensive rats.

  1985cited by this paper
• Central and peripheral indices of sympathetic activity after blood pressure lowering with enalapril (MK-421) or hydralazine in normotensive rats.

  1984cited by this paper
• Cerebral vascular bed in hypertension and consequences for the brain.

  1984cited by this paper
• Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.

  1983cited by this paper
• Body fluid volumes during development of hypertension in the spontaneously hypertensive rat.

  1983cited by this paper
• Hemodynamic effects of the arteriolar vasodilators hydralazine, dihydralazine and endralazine in the conscious spontaneously hypertensive rat.

  1983cited by this paper
• Regression of myocardial hypertrophy and influence of adrenergic system.

  1983cited by this paper
• Simultaneous measurement of 5-hydroxytryptophan and L-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical detection. Measurement of serotonin and catecholamine turnover in discrete brain regions.

  1982cited by this paper
• Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats.

  1982cited by this paper
• Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats.

  1982cited by this paper
• Nitrendipine increases sodium excretion in acutely saline-loaded rats.

  1982cited by this paper
• Physiological aspects of primary hypertension.

  1982cited by this paper
• Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy.

  1981cited by this paper
• Adrenergic facilitation by angiotensin: does it serve a physiological function?

  1981cited by this paper
• Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy.

  1981cited by this paper
• Cardiac hypertrophy: useful adaptation or pathologic process?

  1980cited by this paper
• Studies on the effect of chronic oral administration of minoxidil and hydralazine on vascular function in spontaneously hypertensive rats.

  1980cited by this paper
• Cardiac function and morphology with aging in the spontaneously hypertensive rat.

  1979cited by this paper
• Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats.

  1979cited by this paper
• Time course of baroreceptor resetting in short-term hypotension in the rat.

  1978cited by this paper
• Chronic antihypertensive drug treatment in young spontaneously hypertensive rats: Effects on arterial blood pressure, cardiovascular reactivity and vascular design.

  1978cited by this paper
• Direct and reflex cardiostimulating effects of hydralazine.

  1977cited by this paper
• Cardiac hypertrophy and antihypertensive therapy.

  1977cited by this paper
• A simple specific radioenzymatic assay for the simultaneous measurement of picogram quantities of norepinephrine, epinephrine, and dopamine and in plasma and tissues.

  1977cited by this paper
• The Effects of Minoxidil on Pulmonary and Systemic Hemodynamics in Hypertensive Man

  1977cited by this paper
• Vasodilating drugs: contrasting haemodynamic effects.

  1976cited by this paper
• Norepinephrine Turnover in the Heart and Spleen of the Cardiomyopathic Syrian Hamster

  1975cited by this paper
• An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody.

  1974cited by this paper
• Cardiac Hypertrophy in Spontaneously Hypertensive Rats

  1974cited by this paper
• A Cardiocardiac Sympathovagal Reflex in the Cat

  1973cited by this paper
• Relation of ventricular volume, compliance, and mass in the normal and pulmonary arterial banded canine heart.

  1972cited by this paper
• The turnover of norepinephrine in the heart during experimental hypertension in rats.

  1968cited by this paper
• Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.

  1966cited by this paper

• The effects of renal denervation on blood pressure, cardiac hypertrophy, and sympathetic activity during the established phase of hypertension in spontaneously hypertensive rats

  2024cites this paper
• Renal denervation for hypertensive heart disease and atrial fibrillation

  2024cites this paper
• Renal denervation: a key approach to hypertension and cardiovascular disease

  2024cites this paper
• Kir6.1 and SUR2B and Cantú syndrome.

  2022cites this paper
• Mechanism of Blood–Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury

  2021cites this paper
• Remote Hind-Limb Ischemia Mechanism of Preserved Ejection Fraction During Heart Failure

  2021cites this paper
• The Mechanism of High-Output Cardiac Hypertrophy Arising From Potassium Channel Gain-of-Function in Cantú Syndrome

  2020cites this paper
• Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects

  2019cites this paper
• Factors influencing outcome in patients with obstructive hypertrophic cardiomyopathy - Effects of pharmacotherapy, pacing and surgical myectomy

  2019cites this paper
• Pulmonary Hypertension and ATP-Sensitive Potassium Channels.

  2019cites this paper
• Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability

  2011cites this paper
• Artificial microRNA interference targeting AT1a receptors in paraventricular nucleus attenuates hypertension in rats

  2011cites this paper
• Hydralazine Reverses Stress-Induced Elevations in Blood Pressure, Angiotensin II, Testosterone, and Coronary Pathology in a Social Colony Model

  2011cites this paper
• Vasodilator therapy with hydralazine induces angiotensin AT2 receptor‐mediated cardiomyocyte growth in mice lacking guanylyl cyclase‐A

  2010influential citation
• Ubiquinol-cytochrome-c reductase 7.2 kDa protein of mitochondrial complex III is steroid-responsive and increases in cardiac hypertrophy and hypertension.

  2007cites this paper
• Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study

  2006cites this paper
• Development of angiotensin II-induced hypertension: role of CGRP and its receptor

  2005cites this paper
• Development of angiotensin II-induced hypertension: role of CGRP and its receptor.

  2004cites this paper
• Ventricular PKC‐ϵ and humoral signaling in DOCA‐Salt rats treated with labedipinedilol‐A

  2003cites this paper
• Combined Effects of Enalapril and Spironolactone in Hamsters With Dilated Cardiomyopathy

  2003cites this paper
• Angiotensin II Receptor Subtypes Involved in the Modulation of Purinergic and Adrenergic Vasoconstrictions to Periarterial Electrical Nerve Stimulation in the Canine Splenic Artery

  2003cites this paper
• Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats.

  2002cites this paper
• Comparison of catecholamine release in the isolated adrenal glands of SHR and WKY rats.

  2002cites this paper
• Mortality After Coronary Artery Occlusion in Different Models of Cardiac Hypertrophy in Rats

  2001cites this paper
• Sympathoinhibitory and depressor responses to long-term infusion of nifedipine in spontaneously hypertensive rats on high-salt diet.

  2000cites this paper
• Minoxidil inhibits proliferation and migration of cultured vascular smooth muscle cells and neointimal formation after balloon catheter injury.

  2000cites this paper
• Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil

  2000cites this paper
• The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy.

  2000cites this paper
• Hydralazine decreases blood pressure and endothelin-1 mRNA expression in tissues but not cardiac weight in SHR-SP/Izm rats.

  2000cites this paper
• The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy

  2000cites this paper
• Improvement in fatty acid utilization in relation to a change in left ventricular hypertrophy in spontaneously hypertensive rats.

  2000cites this paper
• Catecholamines in pericardial fluid of normotensive, spontaneously hypertensive and reserpine-treated rats.

  1999cites this paper
• Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats.

  1999cites this paper
• Role of the sympathetic control of vascular resistance in ethanol-clonidine hemodynamic interaction in SHRs.

  1999cites this paper
• Relevance of Angiotensin II for Cardiac Hypertrophy and Failure Induced by Cardiac Volume Overload

  1999cites this paper
• Arterial vasodilation and vascular connective tissue changes in spontaneously hypertensive rats.

  1998cites this paper
• Minoxidil accelerates heart failure development in rats with ascending aortic constriction.

  1998cites this paper
• Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice.

  1998cites this paper
• Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and β‐adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats

  1998cites this paper
• Dietary‐sodium‐induced cardiac remodeling in spontaneously hypertensive rat versus Wistar–Kyoto rat

  1998cites this paper
• Relation of hemodynamic volume load to arterial and cardiac size.

  1997cites this paper
• Antihypertensive Agents that Limit Ventricular Hypertrophy Inhibit Cardiac Expression of Insulin-Like Growth Factor-I

  1997cites this paper
• Hypertension, cardiac hypertrophy and the effects of anaesthesia

  1997cites this paper
• SYMPATHETIC OVERACTIVITY AND CORONARY RISK IN HYPERTENSION

  1997cites this paper
• Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure.

  1997cites this paper
• Effects of hydralazine on renal sympathetic nerve activity in normal and congestive heart failure rats.

  1997cites this paper
• The efficacy of felodipine ER on regression of left ventricular hypertrophy in patients with primary hypertension.

  1996cites this paper
• Clinical relevance of 24 h blood pressure control by 1,4-dihydropyridines.

  1996cites this paper
• Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats.

  1996cites this paper
• Respective role of humoral factors and blood pressure in aortic remodeling of DOCA hypertensive rats.

  1996cites this paper
• Spinal nicotinic receptor expression in spontaneously hypertensive rats.

  1996cites this paper
• Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.

  1996cites this paper
• Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.

  1996cites this paper
• Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat.

  1995cites this paper
• Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure‐overload in the rat

  1995cites this paper
• Treatment in hypertensive cardiac hypertrophy, I. Neuropeptide Y and beta-adrenoceptors.

  1995cites this paper
• Treatment in hypertensive cardiac hypertrophy, II. Postreceptor events.

  1995cites this paper
• Angiotensin Receptors

  1994cites this paper
• Structural and functional consequences of minoxidil-induced cardiac hypertrophy.

  1994cites this paper
• Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

  1994cites this paper
• Left ventricular function of the heart regressed by nifedipine in spontaneously hypertensive rats.

  1994cites this paper
• Role of circulating adrenaline in the pathogenesis of hypertension / Lina Terese Jablonskis.

  1994cites this paper
• Inhibiting the Effects of Angiotensin on Cardiovascular Hypertrophy

  1994cites this paper
• Hypertension and Left Ventricular Hypertrophy: Is Drug Therapy Beneficial?

  1994cites this paper
• Effects of antihypertensive drugs on cardiac hypertrophy.

  1994cites this paper
• Arterial hypertrophy and pressor responsiveness during development of hypertension in spontaneously hypertensive rats

  1994cites this paper
• The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin.

  1994cites this paper
• Structural and functional remodeling of poststenotic arteries in the rat.

  1993cites this paper
• Calcium Antagonists‐ACE Inhibitors Combination Therapy: Objectives and Methodology of Clinical Development

  1993cites this paper
• Effect of regression of cardiac hypertrophy on ischemic myocardial damage in spontaneously hypertensive rats.

  1993cites this paper
• Effects of the arterial vasodilator minoxidil on cardiovascular structure and sympathetic activity in spontaneously hypertensive rats

  1993cites this paper
• Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension.

  1993cites this paper
• Effects of Ro 40-5967, a new calcium antagonist, and enalapril on cardiac remodeling in renal hypertensive rats.

  1993cites this paper
• Long-term alpha 1 blockade does not reverse cardiac hypertrophy in spontaneously hypertensive rats.

  1993cites this paper
• Growth factors and hypertension: Implications for a role in vascular remodelling

  1993cites this paper
• Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy.

  1992cites this paper
• Regression of left ventricular mass in systemic hypertension

  1992cites this paper
• Effects of enalapril and hydralazine treatment and withdrawal upon cardiovascular hypertrophy in stroke-prone spontaneously hypertensive rats.

  1992cites this paper
• Nifedipine in divided doses does not reverse left ventricular hypertrophy in spontaneously hypertensive rats.

  1992cites this paper
• Changes in cardiovascular mass, left ventricular pumping ability and aortic distensibility after calcium antagonists in Wistar—Kyoto and spontaneously hypertensive rats

  1992cites this paper
• Chronic Arterial Vasodilation, Central Hemodynamics, and Cardiac Hypertrophy in Spontaneously Hypertensive Rats

  1992cites this paper
• Dietary sodium restriction and the development of two-kidney, one-clip hypertension in young versus adult rats.

  1992cites this paper
• Effects of lisinopril upon cardiac hypertrophy, central and peripheral hemodynamics and neurohumoral factors in spontaneously hypertensive rats.

  1992cites this paper
• [The hypertensive heart (cardiac hypertension) and secondary drug prophylaxis].

  1992cites this paper
• Sodium-induced cardiac hypertrophy. Cardiac sympathetic activity versus volume load.

  1991cites this paper
• Effects of Two Angiotensin Converting Enzyme Inhibitors and Hydralazine on Coronary Circulation in Hypertensive Rats

  1991cites this paper
• Opposite effects of arterial vasodilators on cardiac vs. arterial hypertrophy and sympathetic activity in spontaneously hypertensive rats.

  1991cites this paper
• Contrasting effects of calcium antagonists vs. arterial vasodilators on cardiac anatomy and sympathetic activity in spontaneously hypertensive rats.

  1991cites this paper
• Chronic hydralazine treatment alters the acute pressure-natriuresis curve in young spontaneously hypertensive rats.

  1991cites this paper
• Quinapril, an Angiotensin Converting Enzyme Inhibitor, Prevents Cardiac Hypertrophy During Episodic Hypertension

  1991cites this paper
• Effects of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats (SHR)--stereological studies on myocytes, capillaries, arteries, and cardiac interstitium.

  1991cites this paper
• Effects of different antihypertensive drug classes on survival in animal models.

  1991cites this paper
• Blood pressure and left ventricular anatomy and function after heart transplantation.

  1991cites this paper
• Antihypertensive drugs and cardiac trophic mechanisms.

  1991cites this paper
• Cardiac remodeling in hypertension and following myocardial infarction: effects of arteriolar vasodilators.

  1991cites this paper
• Influence of left ventricular and coronary vascular hypertrophy on cardiac performance.

  1990cites this paper
• Cardiac volume load as a determinant of the response of cardiac mass to antihypertensive therapy.

  1990cites this paper
• Arterial vasodilators, cardiac volume load, and cardiac hypertrophy in normotensive rats.

  1989cites this paper
• Differential Effects of the Calcium Antagonist, Nisoldipine, Versus the Arterial Vasodilator, Minoxidil, on Ventricular Anatomy, Intravascular Volume, and Sympathetic Activity in Rats

  1989cites this paper
• Left ventricular hypertrophy in hypertensive patients.

  1989cites this paper